NCT05957211View on ClinicalTrials.gov

Improving Drop Instillation Comfort of a Cyclosporine A Solution

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 19, 2023

Primary Completion Date

February 20, 2024

Study Completion Date

February 20, 2024

Conditions
Dry Eye Disease
Interventions
DRUG

0.09% cyclosporine A ophthalmic solution

Cequa is an ophthalmic solution used to treat moderate to severe dry eye disease. The typical dosage is one drop in each eye, twice a day. The drug is packaged in sterile, single use bottles.

Trial Locations (1)

N2J 3G1

University of Waterloo, Waterloo

All Listed Sponsors
collaborator

Sun Pharmaceutical Industries Limited

INDUSTRY

lead

University of Waterloo

OTHER

NCT05957211 - Improving Drop Instillation Comfort of a Cyclosporine A Solution | Biotech Hunter | Biotech Hunter